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Sarcoidosis is a multisystem disease which is most commonly manifested in the pulmonary system. However, extrapulmonary
manifestations have also been frequently reported. Isolated occurrence of sarcoidosis in the genital system is rare and poses
a diagnostic and therapeutic dilemma. Uterine sarcoidosis can present with cervical erosions, endometrial polypoid lesions,
and recurrent serometra. In majority of cases, it is diagnosed by endometrial curettage, but it has also been detected by
examination of hysterectomy, polypectomy, and autopsy specimens. Nonnecrotizing granulomas are the characteristic pathologic
finding of sarcoidosis. However, many infectious and noninfectious etiologies including certain neoplasms can produce similar
granulomatous reactions in the female genital tract. These conditions affect the female genital tract more commonly than
sarcoidosis, and therefore it is important to rule out these conditions first before making a diagnosis of sarcoidosis. Treatment
of sarcoidosis is different from treating these other conditions and the most commonly used systemic or local corticosteroids can
be hazardous if the underlying cause is infection. In this case report, the clinical presentation, histopathology, clinical course, and
treatment of a patient with isolated uterine sarcoidosis are described, and a brief literature review of sarcoidosis of the female genital
tract is provided.
1. Introduction
Sarcoidosis is a multisystem disease of unclear etiology. Any
organ system in the body can be affected by sarcoidosis, and
the classic pathologic finding is the presence of noncaseating
granulomas in the involved organs. Pulmonary sarcoidosis is
the most common manifestation of the disease, accounting
for 90 percent of the cases [1]. Extra pulmonary sarcoidosis is
also common, with skin, eyes, liver, and reticuloendothelial
manifestations accounting for the majority of the cases
(10–25%). The involvement of other organ systems such
as cardiovascular, nervous system, upper respiratory tract,
renal, spleen, thyroid, gastrointestinal tract, musculoskeletal,
and exocrine glands accounts for only a minority of cases
(0.4–5%) [1–4]. Most of the cases with extra pulmonary
sarcoidosis have coexisting pulmonary disease. This was
shown by ACCESS research group where 368/736 (52%)
of their patients had concomitant pulmonary involvement
and only 14/736 (1.9%) of their patients had isolated extra
pulmonary sarcoidosis [5]. Involvement of the female repro-
ductive system by sarcoidosis is very rare. Unlike other extra
pulmonary manifestations, there is not much data available
for this variant of sarcoidosis; whatever little information we
have is mostly based on case reports.
2. Case Description
A 45-year-old African American premenopausal female,
gravida 1 and para 1, chronic active smoker (20 pack years),
and with a past medical history significant for schizophrenia
and chronic obstructive pulmonary disease presented to our
facility with menorrhagia. She was recently treated for latent
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syphilis with penicillin, and she also has genital warts and
herpes virus 2 infections. Three years prior, she presented
with mediastinal adenopathy and thick walled pulmonary
cavities involving both the upper lobes. Flexible bron-
choscopy with bronchoalveolar lavage and transbronchial
biopsies from the right upper lobe revealed nonnecrotizing
granulomas consistent with sarcoidosis. They were negative
for AFB and fungal stains. A diagnosis of primary cavitary
pulmonary sarcoidosis was made, and she was treated with
systemic steroids for twelve months. She responded well to
steroids with complete clinical and radiographic resolutions
(Figures 1(a) and 1(b)). Fourteen months back she presented
with epigastric and right upper quadrant pain of a one-
month duration. Esophagogastroduodenoscopy revealed a
clean gastric ulcer along the lesser curvature and a markedly
erythematous and edematous antrum. Biopsies from the
gastric antrum revealed features of chronic gastritis and non-
necrotizing granulomas which was consistent with her pre-
vious diagnosis of sarcoidosis. Her symptoms resolved with
proton pump inhibitors, and she did not require additional
treatment with steroids for her gastric sarcoidosis. In this
admission, she presented with menorrhagia of two-month
duration. At her baseline, her menstrual cycles are regular
and last for 3-4 days. Her vitals and systemic examinations
were unremarkable. Pelvic examination revealed multiple
subcentimeter white ulcerated lesions involving the labia
majora. Her hemoglobin level was 9.5 gm/dL and the rest
of her routine laboratory workup including complete blood
count, coagulation profile, liver, and renal function tests was
normal. She tested negative for HIV. Chest roentgenogram
did not reveal any abnormality. On transvaginal ultrasonog-
raphy, size of the uterus was 12.1 × 6.5 × 8.2 cm3 with an
endometrial thickness of 6mm. It also revealed an anterior
bodymural fibroid with a submucosal componentmeasuring
4.3 × 3.7 × 4.4 cm3 and a fundal fibroid measuring 2.9 × 2.7 ×
2.9 cm3; her ovaries were normal. She received a short course
of high dose oral contraceptive pills. Punch biopsies from the
vulvar lesions revealed high grade squamous intraepithelial
lesions with features of human papillomavirus infection.
Therapeutic endometrial curettage was performed, and the
histopathological examination of the endometrial tissues
revealedmenstrual phase changes, strands of smoothmuscles
suggestive of uterine myoma, and numerous nonnecrotizing
epithelioid giant cell granulomas (Figures 2(a) and 2(b)).
Stains and cultures for bacteria, fungal, and mycobacteria
were negative, and she was diagnosed with uterine sarcoido-
sis. She has been amenorrhoeic and asymptomatic since she
underwent a therapeutic endometrial curettage.
3. Discussion
Sarcoidosis of the female genital tract is probably the rarest
form of all the extra pulmonary sarcoidosis, accounting for
less than 1% of cases [6]. Based on the literature review, it
seems that the uterus is themost commonly involved organ of
the female genital tract [7, 8]. In 1933, Garland andThompson
first described an autopsy finding of sarcoidosis involving the
uterus in a 28-year-old female. Since its first description in
1933 till 1988, only 21 cases of female genital tract sarcoidosis
(a)
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Figure 1: (a) CT scan of chest revealing cavitary lesions. (b) CT scan
of chest shows resolution of cavitary lesions.
were reported in the literature [6]. In the following years,
there have been just a few more reported cases of uterine
sarcoidosis [9–18].Most of the cases occur in the reproductive
age (21–40 years), although a case of uterine sarcoidosis in a
64-year-old postmenopausal woman has also been described
[19]. Like any other extra pulmonary manifestation of sar-
coidosis, most of the patients have concomitant pulmonary
involvement and the disease seems to occur more frequently
in the Black population. A majority of the patients present
with menstrual irregularities; menorrhagia, metrorrhagia,
and postmenopausal bleeding are more commonly reported
symptoms than amenorrhea [6, 8–17]. Some of the patients
were asymptomatic, and the diagnosis was made based on
examination of the hysterectomy or autopsy specimens [6].
Some cases of uterine sarcoidosis presented with cervical
erosions [8], endometrial polypoid lesions [18], and recurrent
serometra [16]. Others were incidental findings on cervical
pap smear [17] and patients who underwent surgery for
uterine myomas. Endometrial curettage led to the diagnosis
in the majority of the cases; in others the diagnosis was
made on examination of the hysterectomy, polypectomy,
and autopsy specimens [6, 17, 18]. Sampling bias probably
accounts for the increased reporting of uterine sarcoidosis
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Figure 2: (a) Hematoxylin and eosin (H&E) stain at low mag-
nification shows noncaseating granulomas. (b) H&E stain at high
magnification shows a follicular pattern of granulomas, asteroid
bodies, and the absence of necrosis.
compared to other parts of the female genital tract [8].
Cases of uterine sarcoidosis with concomitant involvement
of the ovaries and fallopian tubes have also been reported
[6, 13]. Isolated cases of uterine sarcoidosis are usually
self-limiting and have good prognosis; there seems to be
no detrimental effect on pregnancy outcomes despite the
presence of granulomas in the placenta. A majority of the
patients do not require treatment and can be monitored;
however, systemic steroids may be helpful in symptomatic
patients [8].
Ovarian sarcoidosis is probably the secondmost common
manifestation of female genital tract sarcoidosis. Winslow
and Funkhouser in 1968 described a case of a 28-year-
old female who underwent total abdominal hysterectomy
with bilateral salpingoophorectomy for a cervical lesion [20].
Histopathological examination revealed sarcoid-like lesions
involving the uterus, right fallopian tube, and the right
ovary. Since then there have been other reports of ovarian
involvement by sarcoidosis. Like uterine sarcoidosis, most of
the reported cases occurred in the reproductive age group
[7, 20–25], although a few cases of ovarian sarcoidosis in
postmenopausal women have also been reported [26–28].
Symptoms can be nonspecific, such as fever, malaise, and
abdominal pain [29], or they can presentwith clinical features
concerning for ovarian tumors, such as ovarian enlargement,
weight loss, obstructive uropathy, intraperitoneal mass, and
ascites associated with thickening of the omentum and
peritoneal nodular deposits [7, 21–24, 28]. In these cases,
diagnosis was made based on histopathological findings and
ruling out other causes of granulomatous inflammation.
Some of these patients had elevated CA-125 levels, which
are typically elevated in patients with ovarian tumors and
carcinoma of the female genital tract [22–24, 28]. CA 125
is elevated also in various nongynecologic malignancies
and other benign conditions as well [24]. CA 125 elevation
is probably from increased production by epithelioid cells
present in the granulomas or is due to increased production
by peritoneal cells in response to inflammatory mediators
secreted by sarcoid granulomas [24].There have been reports
of ovarian tumorswith sarcoid-like lesions involving the bone
marrow and regional lymphnodes [29–31].These sarcoid-like
reactions occur in other malignancies, such as lymphomas,
breast cancer, primary lung cancer, renal cell, and gastric
cancers. Usually these reactions are limited in distribution
mostly involving the regional lymph nodes, but multiorgan
involvement consistent with systemic sarcoidosis can develop
simultaneously or following chemotherapy [29–35]. Finding
a sarcoid-like lesion calls for careful examination for other
adjacent lesions that may be masking malignancy. This is
probably due to dysregulation in the Th1/Th2 immunity in
these situations, and sarcoidosis in itself has been shown to
have enhancement of the Th1 immunity [36, 37]. Careful
examination of the pathology specimens is therefore indi-
cated as these granulomatous lesions can easily be confused
with metastatic disease and can cause treatment dilemma.
Most of these patients tend to be symptomatic and have a
good response to steroids with resolution of enlarged ovaries,
intrapelvic mass, ascites, and normalization of CA 125 levels
[7, 22–24, 28].
Involvement of the fallopian tubes commonly occurs in
conjunction with sarcoidosis of the other parts of female
genital tract. In 1954, Cowdell described an autopsy finding
of sarcoidosis involving the fallopian tubes of a 21-year-old
female who died of cardiac sarcoidosis [6, 38]. Subsequently
more cases of tubal sarcoidosis have been described but the
diagnosis was made mostly on pathologic examination of
salpingectomy specimens in patients who were being treated
for other gynecological problems. Most of these patients had
menstrual irregularities, some had fibroids [6], and one of the
patients had dyspareunia and infertility [38]. At the time of
surgery distension of the tubes, pelvic adhesions and miliary
deposits of sarcoid granulomas may be seen involving the
tubes, uterus, ovaries, ligaments, omentum, and intestines
[6, 7, 21, 22, 38]. Vaginal sarcoidosis is the rarest of all, and
only two cases have been reported to date [39, 40]. One of the
cases had pulmonary sarcoidosis who presented with vaginal
itching and irritation and responded to systemic and topical
steroids. Vulval sarcoidosis is another rare manifestation of
sarcoidosis with only five cases reported to date [41–45]. One
of the patients presented with papular rash involving the labia
majora and the perineum; the second one presented with a
painful nodular lesion at the site of the previous episiotomy
site, and the third one presented with vulvar mass. Two of the
patients had pulmonary sarcoidosis. Details on the other two
are not available.
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Nonnecrotizing granulomas are the characteristic patho-
logic finding of sarcoidosis. However, this finding is not
pathognomic of sarcoidosis and many infectious and nonin-
fectious etiologies including certain neoplasms can produce
similar granulomatous reactions in the female genital tract.
Infectious etiologies include tuberculosis, atypical mycobac-
teria, endemic mycosis, actinomycosis, and parasites. Non-
infectious causes like foreign body reaction, Crohn’s disease,
medications, lymphoma, and other neoplastic conditions
and postprocedure or postsurgical granulomas can also
mimic sarcoid granulomas [46–48]. These conditions affect
the female genital tract more commonly than sarcoidosis,
and therefore it is important to rule out these conditions
first before prematurely making a diagnosis of sarcoidosis.
Treatment of sarcoidosis is different from treating these other
conditions and the most commonly used systemic or local
corticosteroids can be hazardous if the underlying cause is
infection.
In conclusion, female genital tract sarcoidosis is rare and
its presentation can mimic other conditions that commonly
affect the female genital tract. Diagnosis is mainly based on
identification of noncaseating granulomas in the involved
organs and ruling out other conditions that can have a
similar histopathology finding. It can affect any age group
but usually occurs in the reproductive age group. Like other
extra pulmonary manifestations of sarcoidosis, the majority
of the patients have pulmonary involvement and the Black
population seems to be affected more frequently than other
races. Increased incidence of uterine sarcoidosis may just
reflect a sampling bias asmost of these cases had concomitant
involvement of other structures of the female genital tract.
Endometrial curettage or even pap smear may be sufficient
to make the diagnosis of uterine sarcoidosis; involvement of
other structures will need a biopsy. Isolated cases may just
require observation but systemic and symptomatic patients
may be given a trial of systemic steroids.
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